Literature DB >> 32012320

Epidemiological Features of NAFLD From 1999 to 2018 in China.

Jianghua Zhou1,2,3, Feng Zhou1,2,3,4, Wenxin Wang1,2,3, Xiao-Jing Zhang1,2,3, Yan-Xiao Ji1,2,3, Peng Zhang1,2,3, Zhi-Gang She1,2,3, Lihua Zhu1,2,3, Jingjing Cai1,2,5, Hongliang Li1,2,3.   

Abstract

With dramatic changes in lifestyles over the last 20 years, nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disorder in China but has not received sufficient attention. NAFLD-related advanced liver disease and its mortality along with its overall disease burden are expected to increase substantially. There is thus an imperative need to clarify the epidemiological features of NAFLD to guide a holistic approach to management. We summarize eight epidemiological features of NAFLD in China over the past two decades using systematic review and meta-analysis methodology. Our data reveal a rapid growth in the NAFLD population, especially among younger individuals. Importantly, there is a strong ethnic difference in body mass index (BMI) and genetic risk of NAFLD compared with the US population. The etiology of advanced liver disease and its complications (e.g., hepatocellular carcinoma) has been altered because of a Westernized lifestyle and the implementation of effective vaccination strategies against viral hepatitis. Regional epidemiological patterns of NAFLD indicate that economics, environment, and lifestyle are critical factors in disease progression. The analysis also indicates that a large number of patients remain undiagnosed and untreated because of the inadequacy of diagnostic tools and the absence of effective pharmacologic therapies. Given the burden of NAFLD, future policy and research efforts need to address knowledge gaps to mitigate the risk burden.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 32012320     DOI: 10.1002/hep.31150

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  77 in total

1.  Effects of Tumor-Derived DNA on CXCL12-CXCR4 and CCL21-CCR7 Axes of Hepatocellular Carcinoma Cells and the Regulation of Sinomenine Hydrochloride.

Authors:  Conghuan Shen; Jianhua Li; Ruidong Li; Zhenyu Ma; Yifeng Tao; Quanbao Zhang; Zhengxin Wang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

Review 2.  Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease.

Authors:  Yuping Zeng; He He; Zhenmei An
Journal:  Dis Markers       Date:  2022-06-29       Impact factor: 3.464

Review 3.  Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease.

Authors:  Ya-Lin Wang; Xiu Zhou; Dong-Li Li; Ji-Ming Ye
Journal:  Acta Pharmacol Sin       Date:  2021-03-17       Impact factor: 6.150

4.  Etiology Exploration of Non-alcoholic Fatty Liver Disease From Traditional Chinese Medicine Constitution Perspective: A Cross-Sectional Study.

Authors:  Ke Zhu; Yongsong Guo; Chenghao Zhao; Shixin Kang; Jialiang Li; Jiexin Wang; Zhaohui Tang; Bing Lin; Weihong Li
Journal:  Front Public Health       Date:  2021-05-12

Review 5.  The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease.

Authors:  Grace Park; Sunhee Jung; Kathryn E Wellen; Cholsoon Jang
Journal:  Exp Mol Med       Date:  2021-05-20       Impact factor: 8.718

Review 6.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

7.  Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver.

Authors:  Harshitha Shanmugam; Agostino Di Ciaula; Domenica Maria Di Palo; Emilio Molina-Molina; Gabriella Garruti; Maria Felicia Faienza; Karel vanErpecum; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2021-05-25       Impact factor: 5.722

Review 8.  Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application.

Authors:  Hang-Yu Li; Ren-You Gan; Ao Shang; Qian-Qian Mao; Quan-Cai Sun; Ding-Tao Wu; Fang Geng; Xiao-Qin He; Hua-Bin Li
Journal:  Oxid Med Cell Longev       Date:  2021-03-01       Impact factor: 6.543

Review 9.  Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Authors:  Agostino Di Ciaula; Salvatore Passarella; Harshitha Shanmugam; Marica Noviello; Leonilde Bonfrate; David Q-H Wang; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 10.  Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ignazio Grattagliano; Agostino Di Ciaula; Jacek Baj; Emilio Molina-Molina; Harshitha Shanmugam; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.